Aiming to become a leading biotech company, pioneering end-to-end generative AI-driven advancements in patient diagnostics and care. Our mission is to accelerate healthcare innovation using our proprietary AI platform, which spans biology, chemistry, and clinical development. This cutting-edge AI technology enables us to swiftly and efficiently advance patient diagnostics, ensuring timely and accurate detection and treatment.
Our globally distributed team allows us to establish a local presence in key regions, with office sites and R&D talents in the U.S., Canada, and the Middle East. This strategic distribution supports the recruitment of top scientific talent, fosters relationships with biopharma partners, investors, and stakeholders, and enhances our global business development efforts.
We collaborate with leading industry partners worldwide, including 10 of the top 20 global pharmaceutical companies. Additionally, we have established partnerships with top institutions, universities, and industry leaders on our core AI projects, furthering our commitment to advancing patient diagnostics and care.
